Gordon E. Moore Medal


The Society of Chemical Industry (SCI America) has established the SCI America Gordon E. Moore Medal as the premier recognition for early career success in innovation, as reflected both in market impact and improvement to the quality of life.  By highlighting extraordinary individuals and their work, the Society aims to promote public understanding of research and development in the modern chemical industries, enhance the interest of students in applied chemistry by providing role models, and emphasize the role of creative research in the global economy.

Gordon Moore webslideBased on the concept that the award name should draw attention to young innovators and connect with to the established Perkin Medal, the SCI America Executive Committee named the award for Gordon E. Moore, co-founder of Intel and a seminal figure in the establishment and development of the semiconductor industry.  Mr. Moore has often described Intel as a chemical company.  As a research chemist and then director of R&D, Gordon Moore carried out pioneering work on silicon transistors, the integrated circuit, semiconductor computer memory, and the microprocessor, while well under the age of 45.

2022 Gordon E. Moore Medal Winner: Kevin Maloney, PhD

Dr. Kevin M. Maloney is Executive Director, Process Chemistry, Merck Research Laboratories. Since joining Merck in 2007, he has held positions of increasing responsibility within the Process Research & Development organization. Throughout his time at Merck, he has successfully pursued a series of breakthrough innovations using enabling technologies in synthetic organic chemistry to develop green, sustainable, and cost-effective manufacturing processes for active pharmaceutical ingredients (API).

Dr. Maloney’s leadership has been instrumental in driving innovation on both the current and future pipeline and developing the next generation of talent. His teams have employed chemocatalysis, flow chemistry and biocatalysis to develop green and sustainable commercial manufacturing processes for ceftolozane sulfate (the antibiotic in ZerbaxaTM), gefapixant (an investigational candidate for the treatment of chronic cough), and islatravir (an investigational candidate for the treatment for HIV). Through his leadership, a revolutionary advance in nucleoside synthesis for islatravir was developed utilizing an enzymatic cascade process that has changed the way chemists think about making nucleosides. Building on this innovative approach, a green and sustainable three-step process utilizing a novel biocatalytic cascade was developed for molnupiravir (LagevrioTM). Additionally, Dr. Maloney has collaborated with his colleague, Dr. Patrick Fier, to establish a research program developing new synthetic methodologies focused on a novel hydroxylation reaction to prepare complex phenols (Maloney-Fier Hydroxylation) and on transformation of sulfonamides for late-stage functionalization, resulting in five publications in top-tier journals.  

As a self-professed green chemistry champion, Dr. Maloney leads Merck’s Green & Sustainable Science Team, which focuses on reinforcing the role of green chemistry in pharmaceutical manufacturing through external and internal advocacy. In this role he has organized the annual Merck Green & Sustainable Science symposium and established API sustainability targets for small molecules as part of the Merck corporate sustainability goals. Over the past five years, Merck has received five consecutive Environmental Protection Agency Green Chemistry Challenge Awards. Lastly, Dr. Maloney is influential in the science community with more than 45 publications, several invited lectures and was recently awarded the inaugural ACS Division of Organic Chemistry Mid-Career Industrial Investigator Award. 

Dr. Maloney holds a PhD from the Massachusetts Institute of Technology under Prof. Rick Danheiser, and a BS from Stetson University. 

Past Gordon E. Moore Medalists

Gordon E. Moore Medal Award Rules